Categories: Health, Innovators

Metavention is a venture-backed medical device company based in Minneapolis, Minnesota developing novel interventional therapies for type 2 diabetes. Founded in 2011, the company is leveraging its unique insights into the role of the sympathetic nervous system in diabetes pathophysiology to develop therapies with the potential to transform the treatment of type 2 diabetes. Metavention has assembled a world-class team of engineers, scientists, clinicians and investors to pursue its mission to improve the lives and health of people with type 2 diabetes. Metabolic Neuromodulation Therapy is not yet commercially approved and is currently undergoing clinical investigation.

View Resource